Author: OurCrowd

[Appdome in PR Newswire] Appdome named winner of AI, Anti-Fraud, and ATO Awards at 2025 RSA Conference

Apr 28, 2025 |

“The recognition across AI/ML for Cyber Resilience, Fraud Prevention, and Account Takeover Protection is a powerful validation of our vision,” said Tom Tovar, CEO and Co-Creator of Appdome. “Mobile businesses face a growing array of attacks, powered by automation, AI, and on-device fraud. We’re proud to provide AI-Native defenses that empower mobile businesses to maintain cyber resilience, preemptively manage and mitigate threats, and protect mobile accounts, transactions, and users quickly and easily.” Read...

Read More

[Anthropic in Globe newswire] Arctic Wolf and Anthropic to advance R&D for next-generation autonomous SOC

Apr 28, 2025 |

EDEN PRAIRIE, Minn., April 28, 2025 (GLOBE NEWSWIRE) — Arctic Wolf, a global leader in security operations, today announced a strategic collaboration with Anthropic, a leading AI safety and research company, to accelerate the development of next-generation autonomous Security Operations Centers (SOCs). This collaboration combines the human augmented AI capabilities of the Arctic Wolf Aurora Platform, home to one of the world’s largest commercial SOCs, with Anthropic’s cutting-edge AI models and deep expertise in building safe, interpretable, and controllable AI systems. Read...

Read More

[Alpha Tau in Globe Newswire] Alpha Tau announces closing of $36.9 million registered direct offering and strategic marketing alliance with Oramed Pharmaceuticals

Apr 28, 2025 |

JERUSALEM, April 28, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that it has successfully closed a registered direct offering (the “offering”) whereby an affiliate of Oramed Pharmaceuticals Inc. (“Oramed”) (Nasdaq: ORMP) (TASE: ORMP) purchased 14,110,121 of Alpha Tau’s ordinary shares, no par value, at a purchase price of $2.612 per ordinary share. The offering closed on April 28, 2025. Read...

Read More